Education
William Zellmer discusses therapeutic options for treating patients with advanced melanoma with Christine Walko and R. Donald Harvey. They explore the epidemiology of melanoma including risk factors for developing the disease and discuss broad categories of new treatments and specific agents in each category. Faculty: Christine M. Walko, Pharm.D., BCOP, FCCP Clinical Pharmacogenomic Scientist Moffitt Cancer Center Associate Professor University of South Florida Morsani College of Medicine Tampa, Florida R. Donald Harvey, Pharm.D., FCCP, BCOP Associate Professor, Hematology/Medical Oncology Director, Phase 1 Clinical Trials Section Winship Cancer Institute Emory University Atlanta, Georgia C.E. Credits: This activity is not eligible for continuing education credits.